$DD · DuPont de Nemours, Inc.
DuPont filed its Q3 2026 10-Q, reporting net sales of $1.868B (+4.1% YoY) and income from continuing operations before taxes of $279M, up from $91M in Q3 2025. Diluted EPS from continuing operations was $1.24 vs $0.70 a year ago. The quarter reflects the post-Electronics separation and post-Aramids divestiture structure, with both prior businesses in discontinued operations. Interest expense fell to $40M from $85M, and acquisition/integration/separation costs dropped to $15M from $62M.
- Q3 net sales rose 4.1% YoY to $1.868B from $1.795B.
- Income from continuing operations before taxes tripled to $279M vs $91M in Q3 2025.
- Interest expense dropped 53% YoY to $40M from $85M, boosting pre-tax income.
- Diluted EPS from continuing operations hit $1.24 vs $0.70 a year ago.
- Acquisition, integration and separation costs fell 76% to $15M from $62M.
DD shares surged 9.30% to $154.44 in regular trading, adding $13.14 — the market is rewarding the clean post-separation earnings power as continuing ops income tripled and separation costs collapsed.
This is the cleanest look yet at standalone DuPont after the Electronics spin and Aramids sale — continuing ops income tripled, proving the slimmed-down structure can deliver.
DuPont's post-Electronics separation results show a leaner specialty-materials pure-play with sharply lower interest expense and separation costs. The 1-for-3 reverse stock split (effective June 24, 2026) retroactively reduced share counts across all periods.
PFAS-related liabilities remain a material overhang, with the Company citing risks around personal injury claims, natural resource damages, and the cost-sharing arrangement with Corteva and Chemours. The Aramids Divestiture also carries post-closing adjustment and dispute risk.